Evidence map›Paper›PMID 37262045›Full record

ArticlePLoS neglected tropical diseases2023

The leishmaniases in Kenya: A scoping review.

Grace Grifferty, Hugh Shirley, Katherine O'Brien, Jason L Hirsch, Adrienne M Orriols, Kiira Lani Amechi, Joshua Lo, Neeharika Chanda, Sarra El Hamzaoui, Jorja Kahn and 7 more

Abstract readScoping Review
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Community Drivers ofTropical medicine and infectious disease · 2026
    Article
  3. Article
  4. Resurgence of visceral and cutaneous leishmaniasis in Kajiado County, Kenya: A coordinated response and entomological survey.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Grace GriffertyDepartment of Cellular and Molecular Biology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.ORCID 0000-0001-8718-3011
Hugh ShirleyAfrican Centre for Community Investment in Health, Nginyang, Baringo County, Kenya.
Katherine O'BrienAfrican Centre for Community Investment in Health, Nginyang, Baringo County, Kenya.
Jason L HirschThe Ohio State University College of Medicine, Columbus, Ohio, United States of America.
Adrienne M OrriolsAfrican Centre for Community Investment in Health, Nginyang, Baringo County, Kenya.
Kiira Lani AmechiDepartment of International Affairs, College of Social Sciences and Humanities, Northeastern University, Boston, Massachusetts, United States of America.
Joshua LoDepartment of Mathematics and Department of Psychology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Neeharika ChandaDepartment of Cellular and Molecular Biology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Sarra El HamzaouiDepartment of Health Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, United States of America.
Jorja KahnDepartment of Behavioral Neuroscience, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Samantha V YapDepartment of Biology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Kyleigh E WatsonDepartment of Health Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, United States of America.
Christina CurranDepartment of Biochemistry, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Amina Atef AbdelAlimDepartment of Biology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
Neeloy BoseDepartment of Bioengineering, College of Engineering, Northeastern University, Boston, Massachusetts, United States of America.
Alissa Link CilfoneNortheastern University Library, Northeastern University, Boston, Massachusetts, United States of America.
Richard WamaiAfrican Centre for Community Investment in Health, Nginyang, Baringo County, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe leishmaniases are a group of four vector-borne neglected tropical diseases caused by 20 species of protozoan parasites of the genus Leishmania and transmitted through a bite of infected female phlebotomine sandflies. Endemic in over 100 countries, the four types of leishmaniasis-visceral leishmaniasis (VL) (known as kala-azar), cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and post-kala-azar dermal leishmaniasis (PKDL)-put 1.6 billion people at risk. In Kenya, the extent of leishmaniasis research has not yet been systematically described. This knowledge is instrumental in identifying existing research gaps and designing appropriate interventions for diagnosis, treatment, and elimination. METHODOLOGY/PRINCIPAL

findingsThis study used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology to determine the state of leishmaniases research in Kenya and identify research gaps. We searched seven online databases to identify articles published until January 2022 covering VL, CL, MCL, and/or PKDL in Kenya. A total of 7,486 articles were found, of which 479 underwent full-text screening, and 269 met our eligibility criteria. Most articles covered VL only (n = 141, 52%), were published between 1980 and 1994 (n = 108, 39%), and focused on the theme of "vectors" (n = 92, 34%). The most prevalent study types were "epidemiological research" (n = 88, 33%) tied with "clinical research" (n = 88, 33%), then "basic science research" (n = 49, 18%) and "secondary research" (n = 44, 16%). CONCLUSION/SIGNIFICANCE: While some studies still provide useful guidance today, most leishmaniasis research in Kenya needs to be updated and focused on prevention, co-infections, health systems/policy, and general topics, as these themes combined comprised less than 4% of published articles. Our findings also indicate minimal research on MCL (n = 1, <1%) and PKDL (n = 2, 1%). We urge researchers to renew and expand their focus on these neglected diseases in Kenya.

Indexed as

LeishmaniaLeishmaniasis, CutaneousLeishmaniasis, MucocutaneousLeishmaniasis, VisceralFemaleHumansKenya

Identifiers

PMID37262045
PMCPMC10263336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.